Male Circumcision Clinical Trial
Official title:
Evaluation of Healing at Three Time Intervals and Potential for Spontaneous Detachment
The objective of this research study is to evaluate the safety and acceptability of the
Shang Ring method of medical male circumcision. The Shang Ring is a new circumcision device
with a potential role in the safe and cost-effective delivery of circumcision services. The
device, developed in China, consists of two concentric plastic rings. Following a ring
penile block, the smaller ring is fitted at the base of the coronal sulcus. The foreskin is
everted over the inner ring and the larger outer ring is secured over the inner ring. The
foreskin is excised and several nicks are made on the incision line to prevent formation of
a constricting, circumferential scab. No suturing is required.
In this study, the investigators will evaluate wound healing of men randomized to removal of
the Shang Ring at one of three different points in time (Days 7, 14 or 21). Leaving the
device on for 14 or 21 days constitutes extended wear of the device.
Sites: Homa Bay District Hospital, Nyanza Province, Kenya
Status | Completed |
Enrollment | 50 |
Est. completion date | January 2011 |
Est. primary completion date | January 2011 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years to 54 Years |
Eligibility |
Inclusion Criteria: - Must be aged 18 and 54 years; - Must be uncircumcised (on examination); - Must be in good general health; - Must be HIV sero-negative, with documentation of testing no mor than one week before the procedure; - Must be free of genital ulcerations or other visible signs of sexually transmissible infections(STI) on examination; - Must be able to understand study procedures and requirements of study participation; - Must agree to return to the healthcare facility for the full schedule of follow-up visits after his circumcision; - Must freely consent to participate in the study and sign a written informed consent form; - Must have a cell phone or access to a cell phone; and, - Must agree to provide the study staff with an address, phone number, or other locator information while participating in the research study. Exclusion Criteria: - Has a known allergy or sensitivity to lidocaine or other local anesthesia; - Takes a medication that would be a contraindication for elective surgery, such as an anticoagulant or steroid; - Has an active genital infection, anatomic abnormality or other condition, which in the opinion of the surgeon, prevents the man from undergoing a circumcision; - Has known bleeding/clotting disorder (e.g. hemophilia); and, - Has thalassemia (an inherited autosomal recessive blood disease). |
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label
Country | Name | City | State |
---|---|---|---|
Kenya | Homa Bay District Hospital | Homa Bay | Nyanza |
Lead Sponsor | Collaborator |
---|---|
FHI 360 | Cornell University, EngenderHealth, Kenya National AIDS & STI Control Programme, Ministry of Medical Services, Kenya |
Kenya,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Asses healing time | Assess healing time from date of circumcision | six weeks | Yes |
Primary | spontaneous detachment of device | Spontaneous detachment from date of circumcision to three weeks post procedure | 21 days | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02242565 -
Safety and Effectiveness of Different ShangRing Device Sizes for Adult Male Circumcision in Lusaka, Zambia
|
N/A | |
Completed |
NCT00993811 -
The Shang Ring: A Novel Male Circumcision Device for HIV Prevention
|
Phase 1 | |
Completed |
NCT02281435 -
Follow Up Study to Evaluate a Non-Surgical Device for Adult Male Circumcision for Screen Failure Subjects
|
N/A | |
Completed |
NCT04263064 -
High Volume Caudal Study
|
Early Phase 1 | |
Completed |
NCT02091726 -
Phase 4 Field Trial of the Unicirc Instrument With Tissue Adhesive
|
N/A | |
Completed |
NCT02309710 -
Male Circumcision (MC) Using the ShangRing™ Device in Malawi
|
Phase 1 | |
Completed |
NCT02167776 -
From Obstacles to Opportunities for Male Circumcision in Tanzania
|
N/A | |
Completed |
NCT01150370 -
A Pivotal Study to Assess the Safety and Efficacy of The PrePex System, a Male Circumcision Device and Methodology for Rapid Scale up of Painless and Bloodless National Circumcision Programs, in Urban and Remote Rural Settings
|
N/A | |
Completed |
NCT01434628 -
Cohort Field Study to Assess the Safety and Efficacy of the PrePex Device for Non-Surgical Circumcision When Performed by Nurses
|
N/A | |
Active, not recruiting |
NCT03914365 -
Pudendal Nerve Block vs Penile Nerve Block for Analgesia During Pediatric Circumcision
|
N/A | |
Completed |
NCT01921608 -
Safety Study of the PrePex Device for Non-Surgical Adult Male Circumcision During Phased in National Implementation in an Effort to Prevent the Spread of HIV
|
N/A | |
Completed |
NCT03634358 -
Bipolar Scissors for Circumcision
|
N/A | |
Completed |
NCT02277795 -
Evaluation of the AccuCirc for Early Infant Male Circumcision in Nyanza, Kenya
|
N/A | |
Completed |
NCT01567436 -
A Prospective Field Study: Introducing the Shang Ring in Routine Clinical Settings
|
Phase 4 | |
Completed |
NCT03223532 -
Randomized Trial Comparing PrePex Day 7 Foreskin Removal Procedure (FRP) to a Day 0 PrePex FRP .
|
N/A |